$CURR

Animoca Brands puts IPO plan on hold after suspending merger talks with Currenc (CURR)

Animoca Brands and Currenc Group suspended merger talks for a Nasdaq listing, citing incompatible timelines. Animoca remains committed to a public listing. Currenc shares fell 0.93% in after-hours trading.

Original reporting
Published Sep 22, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 2:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$CURR
Bearish
medium confidence
Mentioned
$CURR
Relevance
6/10
AlphAI data visualization · based on coindesk.com
Decision brief

The 30-second read

$CURRBearishLow
01

Why it matters

The cancellation removes a near‑term catalyst for both companies, likely dampening short‑term price momentum and delaying liquidity events.

02

Market read

Both stocks may experience short‑term pressure; investors should monitor for alternative listing routes.

03

What to watch

Potential regulatory or timing hurdles that made the original timeline unfeasible.

Relevance 6/10Novelty 6/10Timing: today

Background

Animoca Brands, a Hong Kong‑based digital‑asset investment firm, and Currenc Group were negotiating a reverse merger to achieve a Nasdaq listing. The talks were halted due to mismatched timelines.

Company-level read

Ticker impact

$CURRBearishMedium confidence
Context

Currenc Group shares fell 0.93% after the reverse‑merger talks with Animoca were suspended.

Expected impact

Likely modest further decline pending new deal news.

Evidence & confidence

The suspension removes a potential liquidity event, reducing near‑term upside.

Market effects

No immediate sector impact; crypto‑investment space may see slower listing pipelines.

Minor effect on Hong Kong‑based crypto firms awaiting US listings.

Limited; only relevant to investors tracking Nasdaq‑bound crypto companies.

Counterpoint

The suspension could be strategic, preserving valuation until a better partner emerges.

Key entities

  • Animoca Brands

    Hong Kong‑based digital‑asset investment firm seeking Nasdaq listing.

  • Currenc Group

    Digital‑asset investment company targeted for reverse merger.

Related articles

$GSHighAI 8/10

Goldman Sachs in talks to acquire Palmer Square, Bloomberg says

Goldman Sachs (GS) is in talks to acquire Palmer Square Capital Management, a credit-focused asset manager with $37B in assets, according to Bloomberg. The deal would bolster Goldman's asset management division, particularly in collateralized loan obligations (CLOs), where Palmer Square has a $27B platform. Goldman's CEO has indicated a focus on filling strategic gaps through acquisitions. GS stock fell 1.9% on the news.

HighAI 9/10

Deal Roundup: Carlyle, CVC strike €1bn BauWatch deal, HIG agrees $866m Mistras take-private

Carlyle and CVC DIF to acquire 90% of BauWatch for €1bn, with Haniel retaining 10%. HIG Capital to take Mistras Group private for $866m, or $20.35 per share. Searchlight Capital to finance $1.6bn take-private of Priority Technology at $8.05 per share. Peugeot Invest invests $175m in Mérieux NutriSciences. Thrive Capital distributes 6.3m Oscar Health shares to LPs. Rainmaker raises $100m Series B. Generate Capital sells 12 anaerobic digestion sites.

$WBDHighAI 9/10

Abbreviated Pundit Roundup: The Under 30 Club

American Research Group's poll shows Trump's job approval rating fell to 29%, with 68% disapproving. George W. Bush is helping raise funds for Republican Senate candidates. Paramount settled an antitrust lawsuit, clearing its acquisition of Warner Bros. Discovery for $111B. CNN and others sued over White House access bans.

$WBDHighAI 9/10

California AG settles antitrust lawsuit allowing Paramount-Warner Bros. Discovery merger

California AG Rob Bonta and 12 US states settled an antitrust lawsuit, allowing the $111B Paramount-Warner Bros. Discovery merger. The settlement includes film output quotas, production investment, and cable distribution commitments. Critics argue the terms are weak and pose risks to competition and journalism. The merged entity must maintain a free streaming tier for 5 years. The deal does not endorse the merger but aims to secure worker protections and enforceable guardrails.

$LXEOMed

Why is Lexeo Therapeutics stock gaining today?

Lexeo Therapeutics (LXEO) stock rose 4.2% pre-market after announcing strategic transactions, including the acquisition of Mantle Therapeutics for up to $21.3M. The deal adds four FA programs to its pipeline, with LX3010 showing early positive data. Lexeo also entered three research collaborations and maintained its cash runway guidance. Raymond James reiterated a Strong Buy rating and $24.00 price target.